How to stop a lack of diversity undermining clinical trial data
News
January 19, 2019
Race and ethnicity affect how patients respond to drugs, but participants in clinical trials are disproportionately white. This diversity gap weakens efficacy and could be undermining outcomes for minorities suffering from diseases including HIV, hypertension and cancer.